Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospital Nathalie Caroff, Didier Lepelletier,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study Dominique S.

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Herpes zoster in non-hospitalized children

Amoxycillin/clavulanate resistance as related to β-lactamase content in Escherichia coli strains from community-acquired urinary tract infections in Greece

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98 J. Robert, E. Cambau, K. Grenet, D.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

Epidemiologic characterization of Pseudomonas aeruginosa clinical isolates in a university hospital of southwestern Greece F.A. Paliogianni, M. Christofidou,

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

Odile Launay, Jean-Claude Nguyen Van, Annie Buu-Hoï, J.F. Acar

Structure of grepafloxacin relative to activity and safety profile

High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece A.C. Vatopoulos, E. Varvaresou, E. Petridou,

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Javier Garau, Walter Wilson,

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Sofie Arens, Jan Verhaegen, Ludo Verbist

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model Matthew O'Brien, Thuy Quach,

Cephalosporins: a pharmacological update

Epidemiology of opportunistic infections in AIDS patients

Laboratory diagnosis and biosafety issues of biological warfare agents

Sepsis and neutropenia induced by clozapine

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

Uncommon opportunistic fungi: new nosocomial threats

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital L. Gibold, F. Robin, R.-N.

L. Vogel, E. van Oorschot, H.M.E. Maas, B. Minderhoud, L. Dijkshoorn

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Laboratory diagnosis of Clostridium difficile disease

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

Evaluation of clonal relatedness of extended-spectrum β-lactamase-producing Proteus mirabilis isolates by quantitative antibiogram and RAPD typing Marie-Hélène.

T.M. File Clinical Microbiology and Infection

Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features A.

Community-acquired pneumonia: epidemiologic and clinical consideration

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals G.L. Cartolano,

Pandemic lineages of extraintestinal pathogenic Escherichia coli

C. Gagliotti, L. Nobilio, M.L. Moro

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain L. Vinué, Y. Sáenz, S. Martínez,

Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae isolates in Greece I. Galani, E. Xirouchaki, K. Kanellakopoulou,

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Overview of cefixime use in community-acquired infections

Brita Bruun, Henrik Westh, Jørgen Stenderup

The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece J. Papaparaskevas, J. Stefanou, A. Vatopoulos,

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Incidence, epidemiology and evolution of reduced susceptibility to ciprofloxacin in Neisseria gonorrhoeae in Korea Kyungwon Lee, Yunsop Chong, L. Erdenechemeg,

Javier Aznar, Hassan Safi, Maria C. Conejo, José C. Palomares

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Typing of Clostridium difficile

G. Kahlmeter Clinical Microbiology and Infection

Fernando Baquero, John F

The future of diagnostic bacteriology

Presentation transcript:

Bacterial and epidemiologic study of the resistance to oxyiminocephalosporins in Escherichia coli in a French hospital Nathalie Caroff, Didier Lepelletier, Jean-Luc Orsonneau, Anny Blin, Roger Labia, Hervé Richet, Alain Reynaud Clinical Microbiology and Infection Volume 5, Issue 1, Pages 37-46 (January 1999) DOI: 10.1111/j.1469-0691.1999.tb00096.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 (A) Analytic isoelectric focusing (pH range 4–10) of the β-lactamases extracted from six third-generation resistant Escherichia coli strains (lanes 1–6), Escherichia coli K12 (lane 7) and p453 (pI=7.6) (lane 8). (B) Analytic isoelectric focusing (pH range 8–10) of the β-lactamases extracted from Escherichia coli K12 (lane 1), and six of the third-generation cephalosporin-resistant isolates (lanes 2–7). Clinical Microbiology and Infection 1999 5, 37-46DOI: (10.1111/j.1469-0691.1999.tb00096.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions